[PHP16] Generic Drug Market Access in Japan

[PHP16] Generic Drug Market Access in Japan

2012 Value in health

Yoshida, E. | Toumi, M. | Volume: 15, Issue: 7, Pages: A291, M,

The Japanese generic drug market is not well developed. The generic volume share is 20% of the total market vs. 74% and 64% in the USA and UK. The slow uptake of generics is often explained by the “Brand Lover” profile of Japan. No formal review of drug policy has been undertaken to understand the slow uptake of generics.